AbdolghaderMolaviMD

Infectious Disease • Bar Harbor, ME

Physician

Join to view full profile

Are you Dr. Molavi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 20 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
19 Grason Lane
Bar Harbor, ME 04609
Phone+1 207-669-4966
Is this information wrong?

Summary

Dr. Abdolghader Molavi, MD is an infectious disease specialist in Bar Harbor, Maine. He is currently licensed to practice medicine in New Jersey, Pennsylvania, and California.

Education & Training

Tufts Medical CenterResidency, Internal Medicine, 1966 - 1968
Columbia University Vagelos College of Physicians and SurgeonsClass of 1966

Certifications & Licensure

CA State Medical License 1969 - Present
PA State Medical License 1980 - 2024
NJ State Medical License 1981 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

19 citations
Clostridial endocarditis. Report of a case caused by Clostridium bifermentans and review of the literature.
Scott A. Kolander, Ellen M. Cosgrove, Abdolghader Molavi> ;Archives of Internal Medicine. 1989 Feb 1
38 citations
Necrotizing Fasciitis in Adults due to Group B Streptococcus: Report of a Case and Review of the Literature
John Riefler, Abdolghader Molavi, David A. Schwartz, Mark J. DiNubile> ;Archives of Internal Medicine. 1988 Mar 1
79 citations
Interactions between Antibiotics and Human Neutrophils in the Killing of Staphylococci: STUDIES WITH NORMAL AND CYTOCHALASIN B-TREATED CELLS
Richard K. Root, Raul E. Isturiz, Abdolghader Molavi, Julia A. Metcalf, Harry L. Malech> ;The Journal of Clinical Investigation. 1981 Jan 1
4 citations
In vitro susceptibility of atypical mycobacteria to rifampin.
Abdolghader Molavi, Louis Weinstein> ;Applied Microbiology. 1971 Jul 1
19 citations
Syngamus laryngeus Infection (Syngamosis) with Chronic Cough
Louis Weinstein, Abdolghader Molavi> ;Annals of Internal Medicine. 1971 Apr 1
33 citations
In-Vitro Activity of Erythromycin against Atypical Mycobacteria
Abdolghader Molavi, Louis Weinstein> ;The Journal of Infectious Diseases. 1971 Feb 1
33 citations
Persistent perplexing pyrexia: some comments on etiology and diagnosis.
Abdolghader Molavi, Louis Weinstein> ;The Medical Clinics of North America. 1970 Mar 1
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
Thompson, K. A., Strayer, D. R., Salvato, P. D., Thompson, C. E., Klimas, N., Molavi, A., Hamill, A. K., Zheng, Z., Ventura, D., Carter, W. A.> ;Eur J Clin Microbiol Infect Dis. 1996 Jul
Endocarditis: recognition, management, and prophylaxis.
Molavi, A.> ;Cardiovasc Clin. 1993
Infectious complications in the first 100 days after renal transplantation.
Kumar, M. S., Cridge, P., Molavi, A., Stephan, R., Abouna, G. M.> ;Transplant Proc. 1995 Oct
Metronidazole.
Lefrock, J. L., Molavi, A.> ;Am Fam Physician. 1981 Jul
Necrotizing skin and subcutaneous infections.
LeFrock, J. L., Molavi, A.> ;J Antimicrob Chemother. 1982 Jan
Transient bacteremia associated with diagnostic and therapeutic procedures.
Le Frock, J. L., Molavi, A.> ;Compr Ther. 1982 Feb
Metronidazole.
Molavi, A., LeFrock, J. L., Prince, R. A.> ;Med Clin North Am. 1982 Jan
Clindamycin.
LeFrock, J. L., Molavi, A., Prince, R. A.> ;Med Clin North Am. 1982 Jan
Drug therapy for bacterial osteomyelitis.
Lefrock, J. L., Smith, B. R., Molavi, A.> ;Am Fam Physician. 1984 Jul
Management of osteomyelitis and soft-tissue infections.
LeFrock, J. L., Rolston, K. V., Molavi, A.> ;Del Med J. 1984 May
The nonprophylactic role of cephalosporins in obstetrics and gynecology.
LeFrock, J. L., Smith, B. R., Molavi, A.> ;Bull N Y Acad Med. 1984 May
The nonprophylactic role of cephalosporins in surgery.
LeFrock, J. L., Molavi, A., Smith, B. R.> ;Bull N Y Acad Med. 1984 May
In-vitro and in-vivo comparison of mezlocillin and cefoxitin.
LeFrock, J. L., Molavi, A., Rolston, K., Smith, B., Schell, R., Chandrasekar, P., Carr, B.> ;J Antimicrob Chemother. 1983 May
Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
LeFrock, J. L., Molavi, A., McCloskey, R. V., Rolston, K., Chandrasekar, P., Henao, L., Smith, B. R., Kannangara, W., Schell, R. F., Carr, B. B.> ;Am J Med. 1984 Jul
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
LeFrock, J. L., Molavi, A., Lentnek, A. L., Rolston, K. V., Chandrasekar, P. H., Smith, B. R., Kannangara, W., Schell, R. F., Oaks, S. S., Carr, B. B.> ;J Antimicrob Chemother. 1982 Nov
Cefotaxime therapy for patients with osteomyelitis and septic arthritis.
Mader, J. T., LeFrock, J. L., Hyams, K. C., Molavi, A., Reinarz, J. A.> ;Rev Infect Dis. 1982 Sep 01
Comparative clinical evaluation of mezlocillin and cefoxitin.
LeFrock, J. L., Molavi, A., Carr, B., Schell, R., Smith, B., Rolston, K., Lentnek, A.> ;J Antimicrob Chemother. 1982 Jan
Effectiveness of cefotaxime in gram-negative meningitis.
LeFrock, J. L., Molavi, A., Smith, B., Black, P., Rosenberg, M., Rolston, K., Brodner, R., Chandrasekar, P., Henao, L., Kannangara, D. W.> ;Neurosurgery. 1984 Nov
Join now to see all